Literature DB >> 25093434

Emerging innovation towards safety in the clinical application of ESCs and iPSCs.

Shigeo Masuda1, Shigeru Miyagawa1, Satsuki Fukushima1, Nagako Sougawa1, Emiko Ito1, Maki Takeda1, Atsuhiro Saito1, Yoshiki Sawa1.   

Abstract

Mesh：

Year:  2014        PMID： 25093434     DOI： 10.1038/nrcardio.2014.9-c1

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  16 in total

1.  CD30 is a survival factor and a biomarker for transformed human pluripotent stem cells.

Authors:  Daniella Herszfeld; Ernst Wolvetang; Emma Langton-Bunker; Tung-Liang Chung; Adam A Filipczyk; Souheir Houssami; Pegah Jamshidi; Karen Koh; Andrew L Laslett; Anna Michalska; Linh Nguyen; Benjamin E Reubinoff; Irene Tellis; Jonathan M Auerbach; Carol J Ording; Leendert H J Looijenga; Martin F Pera
Journal:  Nat Biotechnol       Date:  2006-02-26       Impact factor: 54.908

Review 2.  Chemical approaches to stem cell biology and therapeutics.

Authors:  Wenlin Li; Ke Li; Wanguo Wei; Sheng Ding
Journal:  Cell Stem Cell       Date:  2013-09-05       Impact factor: 24.633

Review 3.  Metformin--mode of action and clinical implications for diabetes and cancer.

Authors:  Ida Pernicova; Márta Korbonits
Journal:  Nat Rev Endocrinol       Date:  2014-01-07       Impact factor: 43.330

4.  A Simplified In Vitro Teratoma Assay for Pluripotent Stem Cells Injected Into Rodent Fetal Organs.

Authors:  Shigeo Masuda; Takashi Yokoo; Naomi Sugimoto; Masako Doi; Shuh-Hei Fujishiro; Kengo Takeuchi; Eiji Kobayashi; Yutaka Hanazono
Journal:  Cell Med       Date:  2012-05-08

5.  Activation of AMP-activated protein kinase (AMPK) provides a metabolic barrier to reprogramming somatic cells into stem cells.

Authors:  Alejandro Vazquez-Martin; Luciano Vellon; Pedro M Quirós; Sílvia Cufí; Eunate Ruiz de Galarreta; Cristina Oliveras-Ferraros; Angel G Martin; Begoña Martin-Castillo; Carlos López-Otín; Javier A Menendez
Journal:  Cell Cycle       Date:  2012-03-01       Impact factor: 4.534

Review 6.  Cell therapy for cardiac repair--lessons from clinical trials.

Authors:  Atta Behfar; Ruben Crespo-Diaz; Andre Terzic; Bernard J Gersh
Journal:  Nat Rev Cardiol       Date:  2014-03-04       Impact factor: 32.419

7.  The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells.

Authors:  Barak Blum; Ori Bar-Nur; Tamar Golan-Lev; Nissim Benvenisty
Journal:  Nat Biotechnol       Date:  2009-03-01       Impact factor: 54.908

8.  Metformin limits the tumourigenicity of iPS cells without affecting their pluripotency.

Authors:  Alejandro Vazquez-Martin; Sílvia Cufi; Eugeni Lopez-Bonet; Bruna Corominas-Faja; Cristina Oliveras-Ferraros; Begoña Martin-Castillo; Javier A Menendez
Journal:  Sci Rep       Date:  2012-12-12       Impact factor: 4.379

9.  Inhibition of pluripotent stem cell-derived teratoma formation by small molecules.

Authors:  Mi-Ok Lee; Sung Hwan Moon; Ho-Chang Jeong; Ji-Yeon Yi; Tae-Hee Lee; Sung Han Shim; Yong-Hee Rhee; Sang-Hun Lee; Seok-Jeong Oh; Moo-Yeol Lee; Min-Joon Han; Yee Sook Cho; Hyung-Min Chung; Kwang-Soo Kim; Hyuk-Jin Cha
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 12.779

Review 10.  Present and future perspectives on cell sheet-based myocardial regeneration therapy.

Authors:  Yoshiki Sawa; Shigeru Miyagawa
Journal:  Biomed Res Int       Date:  2013-12-04       Impact factor: 3.411
View more
  7 in total

1.  Reply: Translation of regenerative technologies into clinical paradigms.

Authors:  Atta Behfar; Ruben Crespo-Diaz; Andre Terzic; Bernard J Gersh
Journal:  Nat Rev Cardiol       Date:  2014-08-05       Impact factor: 32.419

2.  Eliminating residual iPS cells for safety in clinical application.

Authors:  Shigeo Masuda; Shigeru Miyagawa; Satsuki Fukushima; Nagako Sougawa; Kaori Okimoto; Chika Tada; Atsuhiro Saito; Yoshiki Sawa
Journal:  Protein Cell       Date:  2015-07       Impact factor: 14.870

Review 3.  Building A New Treatment For Heart Failure-Transplantation of Induced Pluripotent Stem Cell-derived Cells into the Heart.

Authors:  Shigeru Miyagawa; Satsuki Fukushima; Yukiko Imanishi; Takuji Kawamura; Noriko Mochizuki-Oda; Shigeo Masuda; Yoshiki Sawa
Journal:  Curr Gene Ther       Date:  2016       Impact factor: 4.391

Review 4.  Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.

Authors:  Kiwon Ban; Seongho Bae; Young-Sup Yoon
Journal:  Theranostics       Date:  2017-05-17       Impact factor: 11.556

5.  Automated sensing and splitting of stem cell colonies on microraft arrays.

Authors:  Matthew DiSalvo; Nicole M Smiddy; Nancy L Allbritton
Journal:  APL Bioeng       Date:  2019-08-29

Review 6.  The Impact of Acquired Genetic Abnormalities on the Clinical Translation of Human Pluripotent Stem Cells.

Authors:  Alexander Keller; Claudia Spits
Journal:  Cells       Date:  2021-11-19       Impact factor: 6.600

7.  Repair of Ischemic Injury by Pluripotent Stem Cell Based Cell Therapy without Teratoma through Selective Photosensitivity.

Authors:  Seung-Ju Cho; So-Yeon Kim; Ho-Chang Jeong; Hyeonsik Cheong; Doseok Kim; Soon-Jung Park; Jong-Jin Choi; Hyongbum Kim; Hyung-Min Chung; Sung-Hwan Moon; Hyuk-Jin Cha
Journal:  Stem Cell Reports       Date:  2015-11-12       Impact factor: 7.765
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.